![Kathleen Tregoning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Tregoning
Director/Board Member at
SPERO THERAPEUTICS, INC.
Net worth: 155 650 $ as of 2026-05-30
Profile
Kathleen Tregoning is an Independent Director at Spero Therapeutics, Inc. since 2021 and an Independent Director at Compass Pathways Plc starting in 2026.
Formerly, Ms. Tregoning was a Member of the United States Congress, Executive Vice President-External Affairs at Sanofi from 2017 to 2020, Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. from 2020 to 2024, and Senior Vice President-Corporate Affairs at Biogen, Inc. from 2015 to 2017.
Education includes undergraduate studies at Stanford University and graduate studies at Harvard Kennedy School of Government.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-31 | 55,000 ( 0.09% ) | 155 650 $ | 2026-05-30 | |
COMPASS PATHWAYS PLC -.--% | 2026-05-26 | 0 ( -.--% ) | - $ | 2026-05-30 |
Kathleen Tregoning active positions
| Companies | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Director/Board Member | 2021-10-10 |
| COMPASS PATHWAYS PLC | Director/Board Member | 2026-04-05 |
Former positions of Kathleen Tregoning
| Companies | Position | End |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 2024-07-31 |
| SANOFI | Public Communications Contact | 2020-02-29 |
| BIOGEN INC. | General Counsel | 2015-11-30 |
United States Congress | Corporate Officer/Principal | - |
Training of Kathleen Tregoning
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Harvard Kennedy School of Government
 Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
United States Congress |
- Stock Market
- Insiders
- Kathleen Tregoning
